Cargando…

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue

Polycystic ovary syndrome is a complicated hormonal and metabolic disorder. The exact pathogenesis of polycystic ovary syndrome is not clear thus far. Inflammation is involved in the progression of polycystic ovary syndrome. In addition, brown adipose tissue activity is impaired in polycystic ovary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yahui, Lin, Yi, Li, Guoqiang, Yuan, Yuan, Wang, Xuejiao, Li, Na, Xiong, Chuanhao, Yang, Yueying, Ma, Yuhang, Zhang, Zhijian, Ding, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266951/ https://www.ncbi.nlm.nih.gov/pubmed/36930063 http://dx.doi.org/10.1093/biolre/ioad032

Ejemplares similares

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats
por: Wu, Gengxiang, et al.
Publicado: (2020)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Expression and activity of Rac1 is negatively affected in the dehydroepiandrosterone induced polycystic ovary of mouse
por: Maurya, Vineet Kumar, et al.
Publicado: (2014)

Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults
por: Huang, Ying, et al.
Publicado: (2016)

Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin
por: Olaniyan, Olugbemi T, et al.
Publicado: (2020)

Experimentally Induced Hyperinsulinemia Fails to Induce Polycystic Ovary Syndrome-like Traits in Female Rhesus Macaques
por: Zhou, Rao, et al.
Publicado: (2022)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome
por: Harris, R. Alan, et al.
Publicado: (2023)

The Ameliorating Effects of Bushen Huatan Granules and Kunling Wan on Polycystic Ovary Syndrome Induced by Dehydroepiandrosterone in Rats
por: Xu, Yang, et al.
Publicado: (2021)

Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
por: Wu, Haowen, et al.
Publicado: (2023)

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor
por: Roozbeh, Jamshid, et al.
Publicado: (2022)

An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS's Features
por: Kim, Eun-Jeong, et al.
Publicado: (2018)

The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Yang, Song, et al.
Publicado: (2019)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

Yogurt Enriched with Inulin Ameliorated Reproductive Functions and Regulated Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice
por: Li, Tiange, et al.
Publicado: (2022)

Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
por: Guo, Zaixin, et al.
Publicado: (2021)

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
por: Cho, Li-Wei, et al.
Publicado: (2017)

Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis
por: Peng, Fangxin, et al.
Publicado: (2022)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome
por: Song, Xi, et al.
Publicado: (2018)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
por: Liu, Ningning, et al.
Publicado: (2018)

Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report
por: Adefris, Mulat, et al.
Publicado: (2017)

Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
por: Kibbey, Richard G., et al.
Publicado: (2014)

SAT-LB042 Effect of Dehydroepiandrosterone on the Perimenopausal Ovary
por: Luna, Selva, et al.
Publicado: (2019)

Troxerutin protects against DHT-induced polycystic ovary syndrome in rats
por: Gao, Zixuan, et al.
Publicado: (2020)

Brown Adipose Tissue Activation by Cold Treatment Ameliorates Polycystic Ovary Syndrome in Rat
por: Ye, Rongcai, et al.
Publicado: (2021)

C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions
por: Moore, Mary Courtney, et al.
Publicado: (2021)

Hyperandrogenemia due to ingestion of Butea superba
por: Chaiyasit, Kamon, et al.
Publicado: (2012)

The impact of obesity on hyperandrogenemia in Korean girls
por: Kang, Min Jae, et al.
Publicado: (2016)

Oriental Medicine Kyung-Ok-Ko Prevents and Alleviates Dehydroepiandrosterone-Induced Polycystic Ovarian Syndrome in Rats
por: Jang, Minhee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kf5e6067h1hfu03f2039f8gu5s